Home » Parexel launches Connected Journey of newly integrated data-driven services
Parexel launches Connected Journey of newly integrated data-driven services
As life science companies increasingly seek to gain insights from diverse data sources to make drug development more efficient and effective, Parexel International, a global biopharmaceutical services provider, is launching its Connected Journey of data-driven services. This newly integrated network, powered by PAREXEL Analytics capabilities, combines Parexel's technology, processes and expertise to deliver critical intelligence supporting clinical development and commercialization.
Parexel is focused on expediting activities such as protocol design, study start-up, trial execution, regulatory submission and product commercialization. By integrating its data-driven services, Parexel has accelerated a number of key processes. These processes include moving more rapidly from final protocol available to last site initiated, accelerating site activation, and achieving faster turnaround times from database lock to clinical study report. As a result, Parexel is helping biopharmaceutical clients complete clinical trials 22% faster than the industry average.
Parexel's Connected Journey consists of more than 40 innovative data-driven services. Its most recent innovation, the ForeSite clinical trial methodology, integrates therapeutic area expertise, real-time analytics technology, and centralized oversight to more reliably predict site productivity. The solution enables sponsors to optimize feasibility and site and country selection, as well as to more effectively engage and retain sites and patients.
"While drug companies have access to more data sources than ever before, they face challenges in generating and integrating meaningful insights that drive timely and actionable decisions," said Mark A. Goldberg, M.D., president and chief operating officer, Parexel. "Aggregating and leveraging the right data to drive value requires a broad range of services working together to generate insights across the entire drug development and commercialization spectrum. We believe Parexel's global scale and broad technical expertise offer clients a uniquely integrated and comprehensive portfolio—delivered by a single provider."
"The data resources to inform decision making are available, but to yield true value they must all be brought together," said Xavier Flinois, president, Parexel Informatics. "Parexel's Connected Journey moves from single solutions to the industry's largest system of interrelated data-driven innovations. This model seamlessly connects data, technology, processes and multi-functional expertise, and is designed to foster close collaboration with all constituents."
Global News CROs/Service Providers